MLICM
ERAS icon

Metropolitan Life Insurance Company (MetLife)’s Erasca ERAS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,528
Closed -$3.15K – 690
2024
Q1 		$3.15K Buy
1,528
+742
+94% +$1.48K ﹤0.01% 2273
2023
Q4 		$1.67K Sell
786
-3,639
-82% -$7.67K ﹤0.01% 2325
2023
Q3 		$8.72K Hold
4,425
– – ﹤0.01% 2270
2023
Q2 		$12.2K Buy
4,425
+2,505
+130% +$7.14K ﹤0.01% 2190
2023
Q1 		$5.78K Sell
1,920
-2,447
-56% -$8.9K ﹤0.01% 2267
2022
Q4 		$18.8K Hold
4,367
– – ﹤0.01% 2047
2022
Q3 		$34.1K Hold
4,367
– – ﹤0.01% 1721
2022
Q2 		$24.3K Hold
4,367
– – ﹤0.01% 1947
2022
Q1 		$37.6K Sell
4,367
-1,958
-31% -$22.7K ﹤0.01% 1750
2021
Q4 		$98.5K Hold
6,325
– – ﹤0.01% 2495
2021
Q3 		$134K Buy
+6,325
New +$130K ﹤0.01% 2352

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ERAS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Erasca (ERAS) in Q2 2024, closing a stake of 1,528 shares — an estimated $3.15K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ERAS in Q3 2021 and held it in 11 quarters. The position peaked at $134K in Q3 2021. 125 funds tracked by Wall St. Rank hold ERAS as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Erasca position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,528 Erasca shares in Q2 2024, an estimated $3.15K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Erasca in Q3 2021 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Erasca position peaked at $134K in Q3 2021.
  • 125 funds tracked by Wall St. Rank held Erasca as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.